Feraccru®/Accrufer® (Ferric Maltol)

For the treatment of iron deficiency with or without anaemia in adults

Feraccru®/Accrufer® is a stable, non-salt based oral therapy for adults with iron deficiency with or without anaemia. It has a novel mechanism of absorption compared to other oral iron therapies and has been shown to be an efficacious and well-tolerated therapy in a range of placebo-controlled and active comparator phase 3 clinical trials.

Most recently the Phase IIIb AEGIS-H2H study demonstrated that Feraccru®/Accrufer® was non-inferior in delivering improvements in haemoglobin levels compared to intravenously-administered (IV) Ferinject®/Injectafer® (ferric carboxymaltose).

For more information please go to our product website www.feraccru.com